Download Files:
SU5214
$70 – $590
Products Details
Product Description
– SU5214 is a potent VEGFR2 inhibitor extracted from patent US5834504A, SU5214, has IC50s of 14.8 µM (FLK-1) and 36.7 µM (EGFR), respectively[1].
Web ID
– HY-21292
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C16H13NO2
References
– [1]Tang et al. 3-(2′-halobenzylidenyl)-2-indolinone compounds for the treatment of disease. US5834504A.
CAS Number
– 186611-04-1
Molecular Weight
– 251.28
Compound Purity
– 98.29
SMILES
– O=C1NC2=C(C=CC=C2)/C1=C/C3=CC=CC=C3OC
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– DMSO : 100 mg/mL (ultrasonic)
Target
– VEGFR
Isoform
– VEGFR2/KDR/Flk-1
Pathway
– Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
